Table 2.
Prognostic Factors | Classification | X2 | p | RR | CI |
---|---|---|---|---|---|
Completeness of cytoreduction | CC-0 vs. CC-1 | 0.002 | NS | 0.983 | 0.497–1.912 |
PCI after NIPS | ≤11 vs. ≥12 | 0.133 | NS | 1.148 | 0.545–2.419 |
Small bowel PCI after NIPS | ≤2 vs. ≥3 | 0.941 | NS | 1.331 | 0.747–2.375 |
PCI before NIPS | ≤13 vs. ≥14 | 5.189 | 0.023 | 1.789 | 1.085–2.953 |
Histological effects | no responder vs. responder | 2.041 | NS | 0.702 | 0.433–1.140 |
Lymph node metastasis | pN0, pN1 vs. pN2, pN3 | 2.481 | NS | 1.358 | 0.978–1.989 |
Histologic type | Differentiated vs. poorly | 0.669 | NS | 1.305 | 0.669–2.542 |
Cytology before NIPS | Negative vs. positive | 0.7 | NS | 0.822 | 0.519–1.300 |
Cytology after NIPS | Negative vs. positive | 10.637 | 0.001 | 2.631 | 0.471–4.705 |
Peritoneal/Cytologic status | Macroscopic PM vs. P0Cy1 | 0.367 | NS | 0.807 | 0.405–1.611 |
No. of involved peritoneal sectors | ≤5 vs. ≥6 | 0.37 | NS | 1.336 | 0.526–3.393 |
PCI: Peritoneal Cancer Index; CC: Completeness of cytoreduction; PM: peritoneal metastasis; NIPS: neoadjuvant intraperitoneal/systemic chemotherapy; P0Cy1: no peritoneal metastasis but positive cytology.